source Post navigation Clinical trial shows oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes – Medical Xpress Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries – Nature
